Stock Screener App

Frei -

Installieren

30.42

11.35% 3.10

after-market

Handel nachbörslich: 31.00 0.58 +1.91%

Mineralys Therapeutics Inc (MLYS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Mineralys Therapeutics Inc-Aktie (MLYS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	12.01% 41.13	46.75	44.45	60.11	45.17
Operating Income/Loss	12.01% -41.13	-46.75	-44.45	-60.11	-45.17
Nonoperating Income/Loss	20.94% 4.199	3.472	2.236	3.764	4.154
Income/Loss From Continuing Operations Before Tax	14.66% -36.93	-43.27	-42.21	-56.34	-41.01
Income/Loss From Continuing Operations After Tax	14.66% -36.93	-43.27	-42.21	-56.34	-41.01
Net Income/Loss	14.66% -36.93	-43.27	-42.21	-56.34	-41.01
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	7.86% 70.59	65.45	53.16	49.82	49.36
Diluted Average Shares	7.86% 70.59	65.45	53.16	49.82	49.36
Basic Earnings Per Share	21.21% -0.52	-0.66	-0.79	-1.13	-0.83
Diluted Earnings Per Share	21.21% -0.52	-0.66	-0.79	-1.13	-0.83
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

MRNA

$54.26

2.69%

RPRX

$48.70

0.25%

BNTX

$99.47

1.08%

RVMD

$152.54

3.76%

INSM

$146.74

4.34%

ONC

$319.94

3.21%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters